Angiogenesis inhibitors from natural sources by Abd Hamid, Roslida & Awang Hamsin, Dayang Erna Zulaikha





A multi-target strategies targeting on various biochemical and physiological pathways 
implicated in tumour pathogenesis should be developed with the ultimate aim to manage 
patients with cancer and reduce the normal-tissue toxicity. Tumor angiogenesis has been 
recently discovered as an important strategy in treating cancer as most tumors rely on 
angiogenesis to survive, develop, invade and metastasize. Targeting angiogenesis to inhibit 
the progression of tumorigenesis has recently been a focus in developing novel anti-cancer 
development. This is mainly due to the specificity that anti-angiogenic possesses: it targets on 
newly-formed blood vessels and spares the existing ones. With that being said, inhibiting 
angiogenesis is now considered a promising strategy in the development and selection of new 
anti-cancer drug candidates. To date, there are cytotoxic drugs which also exhibit 
antiangiogenic activity but not angiogenesis inhibitors in whole. In this chapter, we will be 
discussing selected natural sources including marine products which have been investigated 
for their antiangiogenic activities. Various methods in validating the effects as well as their 
possible multiple pathways will also be contended in this chapter. 
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